Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Karayama M, et al. Among authors: aoshima y. Eur Respir J. 2023 May 5;61(5):2201634. doi: 10.1183/13993003.01634-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36822633 Free PMC article.
Management of interleukin-2-induced severe bronchoconstriction.
Suda T, Hashizume H, Aoshima Y, Yokomura K, Sato J, Inui N, Nakamura Y, Fujisawa T, Enomoto N, Chida K. Suda T, et al. Among authors: aoshima y. Eur Respir J. 2007 Mar;29(3):612-3. doi: 10.1183/09031936.00152706. Eur Respir J. 2007. PMID: 17329497 Free article. No abstract available.
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Aoshima Y, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Mikamo M, Matsuura S, Kusagaya H, Kaida Y, Uto T, Hashimoto D, Matsui T, Asada K, Suda T. Aoshima Y, et al. Invest New Drugs. 2021 Feb;39(1):210-216. doi: 10.1007/s10637-020-00988-1. Epub 2020 Aug 17. Invest New Drugs. 2021. PMID: 32803701 Clinical Trial.
Transient leukocytopenia following combination therapy for COVID-19.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Tsuchiya K, et al. Among authors: aoshima y. Respir Investig. 2022 Jan;60(1):158-161. doi: 10.1016/j.resinv.2021.09.007. Epub 2021 Oct 9. Respir Investig. 2022. PMID: 34649811 Free PMC article.
47 results